International
US firm Moderna says its Covid-19 vaccine 94.5 effective after clinical trials
A US biotech firm, Moderna Inc on Monday said preliminary data from an ongoing phase three study of its experimental COVID-19 vaccine showed it to be 94.5 percent effective.
“This is a pivotal moment in the development of our COVID-19 vaccine candidate,” said Moderna’s CEO Stephane Bancel in a statement. “This positive interim analysis from our Phase 3 study has given us the first clinical validation that our vaccine can prevent COVID-19 disease, including severe disease.”
Further reports reveal that Moderna expects to have about 20 million doses, earmarked for the US by the end of 2020.
The announcement comes as a promising news in the race for a COVID-19 vaccine as infections surge across the United States and Europe.
READ ALSO: Pfizer’s COVID-19 vaccine attains 90% efficacy in latest trials
This development also comes a week after Pharmaceutical firm Pfizer said an early evaluation of the trial of the Covid-19 vaccine it was inventing showed it was effective in keeping Covid-19 at bay.
Pfizer, which was in partnership with German drugmaker BioNTech, issued just few information from the test, based on the initial formal evaluation of the data by a neutral crew of pundits.
It said the review discovered the vaccine was beyond 90% effective in preventing the disease among volunteers without prior record of coronavirus infection.
Join the conversation
Support Ripples Nigeria, hold up solutions journalism
Balanced, fearless journalism driven by data comes at huge financial costs.
As a media platform, we hold leadership accountable and will not trade the right to press freedom and free speech for a piece of cake.
If you like what we do, and are ready to uphold solutions journalism, kindly donate to the Ripples Nigeria cause.
Your support would help to ensure that citizens and institutions continue to have free access to credible and reliable information for societal development.
INVESTIGATION: In Kwara, multimillion-naira milk processing plant is abandoned, converted to a chicken outlet
After the government spent millions of naira to establish a milk processing plant in Kwara State that would provided jobs...
SPECIAL REPORT: For Sokoto communities, promise of healthcare is akin to death sentence
In this story, ABDULRASHEED HAMMAD delves into the dire realities of Primary Health Care services in Sokoto State, shedding light...
ICYMI…SPECIAL REPORT: NNPCL hides behind PIA to frustrate disclosure, accountability
Nigeria’s major oil company, Nigerian National Petroleum Corporation Limited (NNPCL), in what appears to be a common practice of disregard...
INVESTIGATION: Multi-million naira Ekiti resort center remains uncompleted a decade after
The multimillion-naira project, expected to comprise recreational buildings, now consists of cassava farmland, a bush used for excretion, and a...
SPECIAL REPORT: Torturous experiences of students with disabilities in Oyo tertiary institutions
For students with disabilities in Oyo state-owned tertiary institutions, learning is a torturous and distressing experience, considering the building structures...